Middle East and Africa Lymphedema Treatment Market Growth and Forecast by 2028
Middle East and Africa Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)
Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028- Report Date : Mar 2022
- Report Code : TIPRE00027832
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 87
The lymphedema treatment market in MEA is expected to grow from US$ 195.67 million in 2021 to US$ 237.30 million by 2028; it is estimated to grow at a CAGR of 2.8% from 2021 to 2028.
The utility of robotics for lymphatic surgery allows much greater flexibility and precision compared to previously used laparoscopy. Additionally, the use of robotics proves optimal for both surgeon and patient outcomes and will reveal positive results during the forecast period. For instance, patients who underwent the single-robotic surgery for lymphedema in May 2020 have provided positive anecdotal feedback, including significant clinical improvement such as the ability to wear clothes with the surgeon's significant accomplishments. Further, robots enabled with artificial intelligence (AI) are increasingly assisting in microsurgical procedures in lymphedema surgeries for reducing surgeon variations that could affect patient recovery. For example, for lymphedema surgery, in May 2020, an urogynecology surgeon performed a first-of-its-kind single-port robotic mental harvest by utilizing a free lymph node transfer, intended for minimally invasive surgical treatment of lymphedema. The main objective of this new surgical treatment method is to minimize donor site morbidity with debilitating lymphedema symptoms, so growing use of robotics is expected to fuel the market growth.The coronavirus has shown substantial effects in the Middle East and Africa. Several growing COVID-19 cases have been reported, such as Iran (3,979,727), South Africa (2,236,805), Israel (882,798), UAE (685,462), and Saudi Arabia (528,952) on 4 August 2021. During the COVID-19 pandemic mass drug administration interventions neglected tropical diseases, including lymphatic filariasis have been halted. In view of current pandemic situation WHO issued the recommendation on 1st April 2020 t put all the community surveys, active cases finding activities and mass treatment campaigns on hold.With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the lymphedema treatment market. The MEA lymphedema treatment market is expected to grow at a good CAGR during the forecast period.
MEA Lymphedema Treatment Market Revenue and Forecast to 2028 (US$ Million)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
MEA Lymphedema Treatment Market Segmentation
MEA Lymphedema Treatment Market – By Condition Type
- Primary Lymphedema
- Secondary Lymphedema
MEA Lymphedema Treatment Market – By Treatment Type
- Laser Therapy
- Compression Devices
- Drug Therapy
- Physiological Procedures
- Lymphovenous Anastomosis (LVA)
- Vascularised Lymph Node Transfer (VLNT)
- Debulking Procedures
- Surgical Debulking
- Liposuction
- Others
- Others
MEA Lymphedema Treatment Market – By End-User
- Hospitals
- Clinics
- Clinical Research Organizations
- Others
MEA Lymphedema Treatment Market- By Country
- Saudi Arabia
- South Africa
- UAE
- Rest of MEA
MEA Lymphedema Treatment Market-Companies Mentioned
- 3M Company
- BSN medical GmbH
- Huntleigh Healthcare Limited
- Lohmann & Rauscher GmbH & Co. KG
- Mego Afek ltd
- Sigvaris Group
- Smith & Nephew
Middle East and Africa Lymphedema Treatment Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 195.67 Million |
| Market Size by 2028 | US$ 237.30 Million |
| CAGR (2021 - 2028) | 2.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Condition Type
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDs
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future Analytica
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK Technologies
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample For